SUMMIT THERAPEUTICS PLC's ticker is SMMT and the CUSIP is 86627R102. A total of 15 filers reported holding SUMMIT THERAPEUTICS PLC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $24,000 | -17.2% | 11,000 | -7.6% | 0.00% | – |
| Q2 2018 | $29,000 | -81.2% | 11,900 | 0.0% | 0.00% | – |
| Q1 2018 | $154,000 | +450.0% | 11,900 | +376.0% | 0.00% | – |
| Q4 2017 | $28,000 | -9.7% | 2,500 | 0.0% | 0.00% | – |
| Q3 2017 | $31,000 | +10.7% | 2,500 | 0.0% | 0.00% | – |
| Q2 2017 | $28,000 | – | 2,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Granite Point Capital Management, L.P. | 127,841 | $1,331,000 | 0.91% |
| SPHERA FUNDS MANAGEMENT LTD. | 205,200 | $2,136,000 | 0.27% |
| LANSDOWNE PARTNERS (UK) LLP | 930,000 | $9,681,000 | 0.08% |
| Point72 Asset Management, L.P. | 919,639 | $9,573,000 | 0.08% |
| EverPoint Asset Management, LLC | 100,000 | $1,041,000 | 0.03% |
| AXA S.A. | 376,205 | $3,916,000 | 0.02% |
| First Eagle Investment Management, LLC | 175,000 | $1,822,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 1,228 | $13,000 | 0.00% |
| UBS Group AG | 880 | $9,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 2,500 | $26,000 | 0.00% |